G. H. Tabak Et Al. , "Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study," ARCHIVES OF DERMATOLOGICAL RESEARCH , no.5, 2024
Tabak, G. H. Et Al. 2024. Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study. ARCHIVES OF DERMATOLOGICAL RESEARCH , no.5 .
Tabak, G. H., AKDOĞAN, N., DOĞAN GÜNAYDIN, S., PARLAR, Y. E., BALABAN, H. Y., & ŞİMŞEK, H., (2024). Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study. ARCHIVES OF DERMATOLOGICAL RESEARCH , no.5.
Tabak, Gulsun Et Al. "Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study," ARCHIVES OF DERMATOLOGICAL RESEARCH , no.5, 2024
Tabak, Gulsun H. Et Al. "Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study." ARCHIVES OF DERMATOLOGICAL RESEARCH , no.5, 2024
Tabak, G. H. Et Al. (2024) . "Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study." ARCHIVES OF DERMATOLOGICAL RESEARCH , no.5.
@article{article, author={Gulsun Hazan Tabak Et Al. }, title={Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study}, journal={ARCHIVES OF DERMATOLOGICAL RESEARCH}, year=2024}